Spots Global Cancer Trial Database for Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice
Official Title: Post-Marketing Observational Study (PMOS) to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice (DEVOTE)
Study ID: NCT03310190
Conditions
Interventions
Study Description
Brief Summary: A study to assess the real-life management and use of healthcare resources during the initiation of: * Venetoclax in combination with rituximab is indicated for the treatment of adult participants with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy. * Venetoclax in participants with CLL with the deletion of the short arm of chromosome 17 (del\[17p\]) who have received at least 1 prior therapy or participants with CLL without del(17p) who have received at least 1 prior therapy and for whom there are no other available treatment options.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Calgary /ID# 166416, Calgary, Alberta, Canada
Cross Cancer Institute /ID# 166417, Edmonton, Alberta, Canada
Jack Ady Cancer Centre /ID# 217491, Lethbridge, Alberta, Canada
CancerCare Manitoba /ID# 170751, Winnipeg, Manitoba, Canada
The Moncton Hospital /ID# 166043, Moncton, New Brunswick, Canada
QE II Health Sciences Centre /ID# 213548, Halifax, Nova Scotia, Canada
William Osler Health System /ID# 202049, Brampton, Ontario, Canada
Kingston Health Sciences Centre /ID# 169252, Kingston, Ontario, Canada
Ottawa Hospital Research Institute /ID# 166041, Ottawa, Ontario, Canada
Health Sciences North /ID# 205817, Sudbury, Ontario, Canada
Thunder Bay Regional Research Institute /ID# 204740, Thunder Bay, Ontario, Canada
Jewish General Hospital /ID# 166418, Montreal, Quebec, Canada
CISSSBSL -Hopital regional de Rimouski /ID# 201202, Rimouski, Quebec, Canada
Contact Details
Name: ABBVIE INC.
Affiliation: AbbVie
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
